Form 4: Perrigo EVP Abigail Lennox Receives RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Perrigo Company plc EVP and CSO Abigail Lennox was granted 31,607 restricted stock units on May 13, 2026.

Summary

  • Abigail Lennox, EVP and CSO of Perrigo Company plc, received a grant of 31,607 restricted stock units (RSUs).
  • Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
  • The RSUs are scheduled to vest in three equal annual installments beginning on May 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation practices.

Positives

  • The grant aligns the executive's long-term interests with those of shareholders through equity-based compensation.

Negatives

  • None identified.

Risks

  • The value of the granted RSUs is subject to future fluctuations in Perrigo's share price.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive equity compensation.

Industry Context

StockSavvy.ai notes that this is a routine regulatory disclosure regarding executive compensation and does not signal a change in corporate strategy or financial performance.

Comparison to Industry Standards

  • The use of multi-year vesting schedules for RSU grants is standard practice for executive compensation in the pharmaceutical and consumer goods sectors.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

  • Vesting of the first tranche of RSUs on May 13, 2027.

Key Dates

DateDescription
05/13/2026Date of the RSU grant transaction.
05/13/2027First vesting date for the RSU grant.
05/15/2026Date of filing.

Keywords

Perrigo, PRGO, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.